权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

DESIGN AND TRANSGENIC ANALYSIS OF CELLULAR INHIBITORS

细胞抑制剂的设计和转基因分析

基本信息

批准号：
6696793
负责人：
JOHN R DEDMAN
金额：
$ 4.86万
依托单位：
UNIVERSITY OF CINCINNATI
依托单位国家：
美国
项目类别：
财政年份：
1993
资助国家：
美国
起止时间：
1993-12-01 至 2004-11-30
项目状态：
已结题

项目摘要

The central hypothesis of our project has been that short peptides can be used as potent, specific inhibitors which can be targeted to desire organelles and cell types in order to precisely elucidate cellular pathways. We have shown that the nuclear function of calmodulin in type II cells is critical for murine lung development. The highly flattened type I cells provide a vast cellular surface for O2/CO2 exchange. Lung alveoli are critical for the maintenance of oxygen homeostasis. Type I cells are extremely sensitive to injury from environmental challenges and they do not divide. Following lung damage, type II cells terminally differentiate to repopulate the alveolar epithelium with new type I cells. The research in this project will use novel transgenic approaches to study, in vivo, the role of CaM kinase II- and CalN-regulated pathways involved in lung development and type II cell response to lung injury. CaM kinase II and CalN are the major enzyme systems which mediate Ca/2+/CaM regulation of cellular activities such as secretion, ion fluxes, DNA replication and RNA transcription. Studies are performed in transgenic mice in which the SP-C (surfactant protein C) promoter is used to direct expression of synthetic dominant-negative genes which neutralize the function of CaM Kinase II and CalN in lung type II epithelial cells. These synthetic genes encode peptide concatemers which bind to the active site in the catalytic subunit and cause inhibition of their targeted enzymes in a cell-specific manner. The targeting of these inhibitory peptide concatemers to the lung epithelium will lead to the generation of unique phenotypes in which Ca/2+- activated signal transduction systems are altered. This project will evaluate the role of CaM kinase II and CaIN in lung development and physiological responses to oxidative stress, ozone and silica-induced injury. CaM kinase II and CalN may be required for proper lung function such as fluid and surfactant secretion. It is anticipated that unique mouse lines will be developed that have altered lung compliance, mucous congestion and lung fibrosis. These pathophysiological conditions will result in decreased gas exchange in the alveolus which will cause hypoxemia, plasma pH imbalance and physical disability.

我们项目的中心假设是，短肽可以作为有效的、特异的抑制剂，可以针对所需的细胞器和细胞类型，以便准确地阐明细胞通路。我们已经证明，II型细胞中钙调素的核功能对小鼠肺发育至关重要。高度扁平的I型细胞为O2/CO2交换提供了广阔的细胞表面。肺泡是维持氧稳态的关键。I型细胞对环境挑战造成的伤害极其敏感，它们不会分裂。肺损伤后，II型细胞终末分化，以新的I型细胞重新填充肺泡上皮。该项目的研究将使用新的转基因方法，在体内研究CaM激酶II和CaN调节的通路在肺发育和肺损伤的II型细胞反应中的作用。CaM激酶II和CaN是介导Ca/2+/CaM调节细胞分泌、离子通量、DNA复制和RNA转录等活动的主要酶系统。研究是在转基因小鼠中进行的，在转基因小鼠中，SP-C(表面活性蛋白C)启动子被用来指导合成的显性-负性基因的表达，这些基因中和了肺II型上皮细胞中CaM-Kinase II和Caln的功能。这些合成基因编码与催化亚单位中的活性部位结合的多肽串联体，并以细胞特异性的方式抑制其靶标酶。这些抑制多肽串连分子靶向肺上皮细胞将导致产生独特的表型，其中钙/2+激活的信号转导系统发生改变。本项目将评估CaM激酶II和CaN在肺发育和对氧化应激、臭氧和二氧化硅诱导的损伤的生理反应中的作用。CaM激酶II和Caln可能是正常肺功能所必需的，如液体和表面活性物质的分泌。预计将开发出改变肺顺应性、粘膜充血和肺纤维化的独特的小鼠品系。这些病理生理状况会导致肺泡内气体交换减少，从而导致低氧血症、血浆pH失衡和身体残疾。